-
Something wrong with this record ?
Differences in risk profiles and long-term outcomes in acute heart failure patients with preserved and reduced left ventricular ejection fraction in the Czech Republic: The AHEAD registry sub-analysis
R. Miklik, M. Miklikova, R. Spacek, J. Spinar, K. Zeman, K. Benesova, M. Felsoci, L. Pohludkova, L. Dusek, J. Jarkovsky, P. Lokaj, I. Parenicova, J. Parenica
Language English Country Czech Republic
Document type Comparative Study, Journal Article, Multicenter Study
NLK
Directory of Open Access Journals
from 2001
Free Medical Journals
from 1998
Medline Complete (EBSCOhost)
from 2007-06-01
ROAD: Directory of Open Access Scholarly Resources
from 2001
PubMed
33020669
DOI
10.5507/bp.2020.038
Knihovny.cz E-resources
- MeSH
- Acute Disease MeSH
- Time Factors MeSH
- Risk Assessment MeSH
- Middle Aged MeSH
- Humans MeSH
- Registries MeSH
- Retrospective Studies MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Heart Failure mortality physiopathology MeSH
- Stroke Volume * MeSH
- Treatment Outcome MeSH
- Patient Readmission MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Multicenter Study MeSH
- Comparative Study MeSH
- Geographicals
- Czech Republic MeSH
BACKGROUND: The latest European heart failure guidelines define patients as those with reduced (HFrEF), mid-range, and preserved (HFpEF) left ventricular ejection fraction (LVEF; <40%, 40%-49%, and ≥50%, respectively). We investigated the causes of rehospitalizations/deaths in our institution's heart failure patients and focused on differences in the clinical presentation, risk profile, and long-term outcomes between the HFrEF and HFpEF groups in a real-life scenario. METHODS AND RESULTS: We followed 1274 patients discharged from heart failure hospitalization in 2 centres. The mean patient age was 75.9 years, and men and women were represented equally. During the minimal follow-up of 2 years, 57% of patients were hospitalised for any cause, 24.9% for decompensated heart failure, and 43.3% for any cardiovascular cause. A total of 36.1% of patients died, either with prior (11.8%) or without prior (24.3%) heart failure rehospitalization. Heart failure was also the most frequent cause of cardiovascular hospitalization, followed by gastrointestinal problems, infections, and tumours for noncardiovascular hospitalizations. Patients with HFrEF had different baseline characteristics and risk profiles, experienced more hospitalizations for acute heart failure (28.6% vs 20.2%, P=0.012), and had higher cardiovascular mortality (82.4% vs 63.5%, P<0.001) when compared with HFpEF patients. Overall mortality and rehospitalization rates were similar. CONCLUSION: Within 2 years, half of the patients died and/or were hospitalised for acute decompensation of heart failure, and only one-third of the patients survived without any hospitalization. HFrEF and HFpEF patients were confirmed to be different entities with diverse characteristics, risk profiles, and cardiovascular event rates.
Cardiology Podlesi Hospital Trinec Czech Republic
Centre of Cardiovascular and Transplant Surgery Pekarska 53 Brno Czech Republic
Department of Cardiology University Hospital Brno Czech Republic
Department of Internal Medicine Hospital Frydek Mistek Frydek Mistek Czech Republic
Institute of Biostatistics and Analysis Faculty of Medicine Masaryk University Brno Czech Republic
References provided by Crossref.org
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21028021
- 003
- CZ-PrNML
- 005
- 20211129142955.0
- 007
- ta
- 008
- 211105s2021 xr d f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.5507/bp.2020.038 $2 doi
- 035 __
- $a (PubMed)33020669
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Miklík, Roman $7 xx0104559 $u Cardiology, Podlesi Hospital Trinec, Czech Republic $u Internal Department, Military Hospital Brno, Czech Republic
- 245 10
- $a Differences in risk profiles and long-term outcomes in acute heart failure patients with preserved and reduced left ventricular ejection fraction in the Czech Republic: The AHEAD registry sub-analysis / $c R. Miklik, M. Miklikova, R. Spacek, J. Spinar, K. Zeman, K. Benesova, M. Felsoci, L. Pohludkova, L. Dusek, J. Jarkovsky, P. Lokaj, I. Parenicova, J. Parenica
- 504 __
- $a Literatura
- 520 9_
- $a BACKGROUND: The latest European heart failure guidelines define patients as those with reduced (HFrEF), mid-range, and preserved (HFpEF) left ventricular ejection fraction (LVEF; <40%, 40%-49%, and ≥50%, respectively). We investigated the causes of rehospitalizations/deaths in our institution's heart failure patients and focused on differences in the clinical presentation, risk profile, and long-term outcomes between the HFrEF and HFpEF groups in a real-life scenario. METHODS AND RESULTS: We followed 1274 patients discharged from heart failure hospitalization in 2 centres. The mean patient age was 75.9 years, and men and women were represented equally. During the minimal follow-up of 2 years, 57% of patients were hospitalised for any cause, 24.9% for decompensated heart failure, and 43.3% for any cardiovascular cause. A total of 36.1% of patients died, either with prior (11.8%) or without prior (24.3%) heart failure rehospitalization. Heart failure was also the most frequent cause of cardiovascular hospitalization, followed by gastrointestinal problems, infections, and tumours for noncardiovascular hospitalizations. Patients with HFrEF had different baseline characteristics and risk profiles, experienced more hospitalizations for acute heart failure (28.6% vs 20.2%, P=0.012), and had higher cardiovascular mortality (82.4% vs 63.5%, P<0.001) when compared with HFpEF patients. Overall mortality and rehospitalization rates were similar. CONCLUSION: Within 2 years, half of the patients died and/or were hospitalised for acute decompensation of heart failure, and only one-third of the patients survived without any hospitalization. HFrEF and HFpEF patients were confirmed to be different entities with diverse characteristics, risk profiles, and cardiovascular event rates.
- 650 _2
- $a akutní nemoc $7 D000208
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a srdeční selhání $x mortalita $x patofyziologie $7 D006333
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a znovupřijetí pacienta $7 D010359
- 650 _2
- $a registrace $7 D012042
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a hodnocení rizik $7 D018570
- 650 12
- $a tepový objem $7 D013318
- 650 _2
- $a časové faktory $7 D013997
- 650 _2
- $a výsledek terapie $7 D016896
- 651 _2
- $a Česká republika $7 D018153
- 655 _2
- $a srovnávací studie $7 D003160
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a multicentrická studie $7 D016448
- 700 1_
- $a Pavlušová, Marie $7 xx0224364 $u Department of Cardiology, University Hospital Brno, Czech Republic $u Medical Faculty, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Špaček, Radim, $d 1987- $7 xx0243799 $u Department of Internal Medicine, Hospital Frydek-Mistek, Frydek-Mistek, Czech Republic
- 700 1_
- $a Špinar, Jindřich, $d 1960- $7 nlk20030128322 $u Department of Cardiology, University Hospital Brno, Czech Republic $u Medical Faculty, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Zeman, Kamil $7 xx0229780 $u Department of Internal Medicine, Hospital Frydek-Mistek, Frydek-Mistek, Czech Republic
- 700 1_
- $a Benešová, Klára $7 xx0224941 $u Institute of Biostatistics and Analysis, Faculty of Medicine, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Felšőci, Marián $7 xx0096965 $u Department of Cardiology, University Hospital Brno, Czech Republic
- 700 1_
- $a Pohludková, Ludmila $7 xx0109041 $u Department of Internal Medicine, Hospital Frydek-Mistek, Frydek-Mistek, Czech Republic
- 700 1_
- $a Dušek, Ladislav, $d 1967- $7 mzk2003181727 $u Institute of Biostatistics and Analysis, Faculty of Medicine, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Jarkovský, Jiří, $d 1976- $7 stk2008461294 $u Institute of Biostatistics and Analysis, Faculty of Medicine, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Lokaj, Petr $7 xx0106652 $u Department of Cardiology, University Hospital Brno, Czech Republic $u Medical Faculty, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Pařenicová, Ilona $7 xx0137950 $u Centre of Cardiovascular and Transplant Surgery, Pekarska 53, Brno, Czech Republic
- 700 1_
- $a Pařenica, Jiří $7 xx0101388 $u Department of Cardiology, University Hospital Brno, Czech Republic $u Medical Faculty, Masaryk University, Brno, Czech Republic
- 773 0_
- $w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia $x 1213-8118 $g Roč. 165, č. 1 (2021), s. 34-42
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33020669 $y Pubmed
- 910 __
- $a ABA008 $b A 1502 $c 958 $y p $z 0
- 990 __
- $a 20211105 $b ABA008
- 991 __
- $a 20211116152537 $b ABA008
- 999 __
- $a ok $b bmc $g 1728683 $s 1148566
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 165 $c 1 $d 34-42 $e 20201001 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
- LZP __
- $b NLK118 $a Pubmed-20211105